Quick answer: Semaglutide may appear not to work because you are still on an introductory dose, have not used it long enough, are losing weight more slowly than expected, have reached a normal plateau, or have another factor affecting appetite and weight. Improper administration, missed doses, calorie-dense foods, reduced activity, poor sleep, certain medications and medical conditions may also contribute.

Do not increase the dose, inject early, combine GLP-1 medications or obtain an unapproved product in an attempt to accelerate weight loss. The safest next step is a structured review with your prescribing clinician.

First determine which situation applies to you

“Semaglutide is not working” can mean several different things:

1. You recently started and have not lost weight yet.
2. Your appetite is lower, but the scale has barely changed.
3. You initially lost weight and then reached a plateau.
4. Hunger has returned after months of treatment.
5. You are regaining weight despite continuing treatment.
6. You stopped treatment and are now regaining weight.

These situations do not necessarily have the same explanation or solution.

How much weight loss is realistic with semaglutide?

In the STEP 1 clinical trial, adults with overweight or obesity who did not have diabetes received once-weekly injectable semaglutide 2.4 mg or placebo, together with lifestyle intervention. After 68 weeks, the semaglutide group lost an average of 14.9% of its starting body weight, compared with 2.4% in the placebo group.[1]

However, an average is not a guarantee:

• Some participants lost considerably more.
• Some lost less than 5%.
• Some stopped treatment.
• Participants received regular lifestyle counseling and monitoring.
• The trial included a gradual 16-week dose-escalation period.
• Results may differ in people with type 2 diabetes or other medical conditions.

A person starting at 250 pounds would lose approximately 37 pounds if they matched the 14.9% trial average. This calculation illustrates the percentage; it does not predict an individual result.

When should semaglutide start working?

Semaglutide begins affecting appetite and digestion before most people reach the full maintenance dose, but visible weight loss may take longer.

The standard escalation schedule for injectable Wegovy has traditionally begun with a low introductory dose and increased gradually. These initial doses are intended primarily to help the body adjust and reduce gastrointestinal side effects—not to produce maximum weight loss immediately.

In STEP 1, average weight declined progressively over many months and reached its lowest point at approximately week 60.[1] Therefore, judging the medication after the first few injections can be misleading.

Contact your prescriber if you have questions about your particular product, dose or schedule. Different semaglutide brands and formulations are not automatically interchangeable.

1. You are still taking an introductory dose

One of the most common explanations is that treatment is still in the dose-escalation phase.

A low starting dose may reduce appetite noticeably for some people, while others feel very little. Neither response reliably predicts the final result after reaching an appropriate maintenance dose.

What to do

• Confirm your current dose and schedule with your prescriber.
• Ask whether you are following the intended escalation plan.
• Continue tracking appetite, weight and side effects.
• Do not increase the dose ahead of schedule.
• Do not take an additional injection because hunger returns before the next dose.

Dose escalation may need to be delayed when nausea, vomiting, constipation or other adverse effects remain significant. Tolerability and safety are more important than reaching the highest dose quickly.

2. You have not been taking it long enough

Online testimonials can create the impression that everyone loses a dramatic amount of weight in the first month. Clinical trials do not support that expectation.

Meaningful weight loss generally develops over months, especially because the dose is increased gradually. Early changes can also be obscured by:

• Fluid retention
• Constipation
• Menstrual-cycle changes
• Sodium intake
• Recent exercise
• Different clothing
• Weighing at different times

What to do

Use consistent measurements:

• Weigh yourself on the same scale.
• Measure at roughly the same time of day.
• Wear similar clothing.
• Follow weekly trends rather than daily fluctuations.
• Consider measuring waist circumference monthly.

A four-week trend usually provides more useful information than comparing two isolated weigh-ins.

3. The medication is reducing appetite, but calorie intake remains high

Semaglutide supports weight loss primarily by helping reduce appetite, food cravings and energy intake. It does not make calories irrelevant.

Small portions of calorie-dense foods can still provide more energy than expected. Common examples include:

• Sweetened beverages
• Alcohol
• Specialty coffee drinks
• Cooking oils
• Dressings and sauces
• Nuts and nut butters
• Cheese
• Restaurant meals
• Frequent grazing
• Protein shakes containing large amounts of added sugar or fat

This is not an argument for an extreme diet. Severe restriction can increase fatigue, nutritional deficiencies, muscle loss and the likelihood of abandoning the plan.

What to do

For one or two weeks, record meals, snacks and beverages honestly without trying to make the record look “perfect.” Look for patterns rather than blaming yourself.

Useful questions include:

• Are liquid calories contributing?
• Are portions increasing late in the day?
• Do restaurant meals occur frequently?
• Does alcohol reduce dietary control?
• Are weekends substantially different?
• Are you eating after becoming comfortably full?

A registered dietitian can help identify a sustainable calorie deficit while preserving adequate protein, fiber and micronutrients.

4. Your weight has reached a normal plateau

A plateau does not necessarily mean semaglutide suddenly stopped working.

As body weight decreases:

• A smaller body uses less energy.
• Resting energy expenditure may decline.
• The same diet may no longer produce the previous calorie deficit.
• Biological signals can increase hunger and defend the lower weight.
• Early water-weight changes are no longer contributing.

Clinical-trial curves also show that weight loss eventually slows rather than continuing indefinitely.[1,2]

A plateau is better defined as a sustained trend over several weeks—not a few days without movement.

What to do

Review:

• Your weight trend over at least four weeks
• Current food portions
• Protein and fiber intake
• Physical activity
• Resistance training
• Sleep
• Alcohol intake
• Medication adherence

If you have maintained a clinically meaningful loss, weight stability itself may represent treatment benefit. Without treatment, weight might otherwise increase.

5. Activity decreased without you noticing

Some people eat less on semaglutide but also move less because of fatigue, nausea, loss of routine or reduced body mass. This can narrow the expected calorie deficit.

Formal exercise is only part of daily energy expenditure. Walking, standing, household tasks and other routine movement also matter.

What to do

Unless your clinician has restricted activity, build movement gradually:

• Track your usual step count before setting a target.
• Add brief walks after meals.
• Break up prolonged sitting.
• Include resistance training two or more days per week when appropriate.
• Progress slowly if you have pain, cardiovascular disease or limited exercise experience.

Resistance exercise and adequate protein are especially important because weight loss can include lean tissue as well as fat. Exercise should complement nutrition and medical treatment, not punish you for eating.

6. Missed doses or administration problems are reducing exposure

Treatment may be less effective when doses are repeatedly missed, the wrong amount is used or the medication is not administered as intended.

Possible problems include:

• Forgetting injections
• Confusing milligrams with milliliters
• Using the wrong product or concentration
• Removing the device before the dose is complete
• Incorrect storage
• Using medication beyond its expiration date
• Following instructions intended for a different semaglutide formulation

Dosing errors are particularly concerning with compounded products supplied in multidose vials because concentrations and measuring devices may vary.

What to do

Ask your pharmacist or prescriber to verify:

1. The exact product
2. The prescribed dose
3. The dosing interval
4. Storage requirements
5. Injection technique
6. What to do after a missed dose

Do not estimate doses, reuse needles or transfer instructions from one product to another.

If you think you administered too much semaglutide, contact your prescriber, Poison Control in the United States at 1-800-222-1222, or emergency services if severe symptoms develop.

7. Sleep, stress or alcohol is affecting appetite and weight

Insufficient sleep can increase hunger, reduce activity and make food choices more difficult. Chronic stress can produce similar behavioral effects.

Alcohol can interfere in several ways:

• It supplies calories without much satiety.
• It can reduce dietary restraint.
• It may worsen reflux, nausea or dehydration.
• It may increase the risk of low blood sugar in susceptible people using other diabetes medications.
• Heavy use may contribute to pancreatitis and liver disease.

What to do

Aim for a consistent sleep schedule and discuss symptoms such as loud snoring, witnessed breathing pauses, morning headaches or severe daytime sleepiness with a clinician. These can suggest obstructive sleep apnea.

If alcohol is contributing, reducing it may improve both weight-management efforts and medication tolerability. People who drink heavily or may be physically dependent should seek medical guidance before abruptly stopping.

8. Another medication may promote weight gain

Some prescription medications can increase appetite, cause fluid retention or affect metabolism. Examples may include certain:

• Antipsychotics
• Antidepressants
• Mood stabilizers
• Corticosteroids
• Insulin and insulin secretagogues
• Antiseizure medications
• Antihistamines

The degree of effect varies substantially, and these medications may be essential for your health.

What to do

Bring a complete list of prescription drugs, over-the-counter products and supplements to your clinician.

Do not abruptly discontinue psychiatric medication, steroids, insulin or another prescribed treatment. Instead, ask whether:

• The medication may contribute to weight gain
• An alternative exists
• The dose remains appropriate
• Additional monitoring is needed

The risks of changing treatment may outweigh its effect on weight.

9. An untreated medical condition may be contributing

Semaglutide cannot correct every cause of weight gain or difficulty losing weight.

Depending on the history and examination, a clinician may consider:

• Hypothyroidism
• Polycystic ovary syndrome
• Cushing syndrome
• Obstructive sleep apnea
• Depression or binge-eating disorder
• Menopause-related changes
• Fluid retention from heart, kidney or liver disease
• Poorly controlled diabetes

Routine broad hormone testing is not automatically necessary for everyone. Testing should be guided by symptoms, risk factors and clinical findings.

Seek prompt evaluation for

• Rapid unexplained weight gain
• New leg swelling
• Shortness of breath
• Abdominal swelling
• Marked weakness
• Easy bruising with other concerning symptoms
• Severe fatigue or cold intolerance
• Excessive thirst and urination
• Loss-of-control eating or recurrent binge episodes

Sudden weight gain accompanied by swelling or breathing difficulty may represent fluid accumulation rather than increased body fat.

10. Semaglutide may not provide an adequate individual response

Even when semaglutide is used correctly, not everyone achieves the expected result. Differences in biology, medical conditions, side effects and adherence can influence response.

A clinician should not evaluate efficacy solely by comparing you with a social-media transformation. More useful questions are:

• What percentage of starting weight have you lost?
• Has waist circumference changed?
• Has blood pressure, glucose or cholesterol improved?
• Are hunger and food cravings better controlled?
• Are you tolerating treatment?
• Have you had enough time at an appropriate therapeutic dose?
• Is the medication affordable and sustainable?

If the response remains inadequate, the prescriber may reassess the diagnosis, treatment plan and available alternatives. Switching medications may be reasonable for selected patients, but it should be medically supervised.

What not to do when semaglutide seems ineffective

Avoid these potentially unsafe responses:

• Taking more than prescribed
• Injecting more frequently than prescribed
• Combining semaglutide with tirzepatide
• Using Ozempic and Wegovy together
• Restarting at a high dose after a prolonged interruption
• Purchasing medication from an unverified online source
• Using someone else’s prescription
• Following dosing instructions from social media
• Severely restricting food or fluid
• Continuing despite persistent vomiting or dehydration

More medication is not always better. Excessive dosing can cause prolonged nausea, vomiting, dehydration, kidney injury and other complications.

A practical checklist before your follow-up appointment

Bring the following information to your clinician:

Information	What to record
Medication	Exact brand or compounded product
Current dose	Include units and concentration if applicable
Schedule	Injection day and missed doses
Treatment duration	Start date and dates of dose changes
Weight	Starting weight and recent weekly measurements
Waist	Optional monthly measurement
Appetite	Better, unchanged or returning
Side effects	Nausea, vomiting, constipation, reflux or pain
Nutrition	Typical meals, snacks, drinks and alcohol
Activity	Walking, resistance exercise and recent changes
Other medications	Prescriptions, OTC drugs and supplements
Relevant symptoms	Fatigue, snoring, swelling, thirst or binge eating

This information helps distinguish a dose or adherence issue from a normal plateau, lifestyle factor, adverse effect or medical condition.

When should treatment be reassessed?

There is no universal date at which everyone should be labeled a nonresponder. The appropriate timeline depends on the formulation, dose, tolerability and medical indication.

Request a clinician review if:

• You have completed dose escalation but have had little meaningful response.
• Your weight has been stable or increasing for several weeks.
• Hunger has returned substantially.
• You cannot tolerate the dose needed for treatment.
• Cost or supply repeatedly interrupts therapy.
• You are unsure whether the medication was stored or administered correctly.
• You have new symptoms suggesting another condition.

The clinician may review adherence, nutrition, activity, medications, laboratory testing and whether continued semaglutide remains appropriate.

What if you stopped semaglutide and regained weight?

Weight regain after stopping does not prove that semaglutide permanently damaged your metabolism or that you failed.

In an extension of STEP 1, participants regained approximately two-thirds of their prior weight loss during the year after semaglutide and lifestyle intervention were withdrawn.[3] This supports viewing obesity as a chronic condition that often requires long-term management.

Do not restart your previous high dose without medical advice. After a significant interruption, a clinician may recommend restarting more gradually to reduce gastrointestinal adverse effects.

When to seek urgent medical care

Contact a clinician promptly or seek emergency care for:

• Severe, persistent abdominal pain, especially if it radiates to the back
• Repeated vomiting or inability to keep fluids down
• Fainting, confusion or severe weakness
• Signs of dehydration, such as very little urination
• Facial or throat swelling, difficulty breathing or widespread hives
• Yellow skin or eyes
• Severe right-upper-abdominal pain
• Severe low-blood-sugar symptoms
• Sudden vision changes
• Rapid weight gain with leg swelling or shortness of breath

These symptoms should not be treated as an ordinary weight-loss plateau.

Frequently asked questions

Why am I not losing weight on semaglutide after one month?

You may still be on an introductory dose, and one month is usually too early to judge the full response. Confirm your dose, technique and escalation plan with your prescriber.

Why did semaglutide work at first and then stop?

Early weight loss often slows because the body requires fewer calories at a lower weight and adapts biologically. Fluid changes, decreased activity, changing food intake and a normal plateau may also contribute.

Can semaglutide suddenly stop suppressing appetite?

Appetite can fluctuate, and the initial sensation of strong appetite suppression may become less noticeable. That does not necessarily mean all treatment benefit has disappeared. Persistent return of hunger warrants a review of dose, adherence, storage and the overall plan.

Should I increase my semaglutide dose?

Only the prescribing clinician should change the dose. Increasing early or beyond the prescribed amount can increase adverse effects without guaranteeing more weight loss.

Does semaglutide work without dieting?

Semaglutide can reduce appetite, but clinical trials combined medication with nutrition and physical-activity counseling. Sustainable food choices remain part of treatment; an extreme or highly restrictive diet is unnecessary.

Should I switch from semaglutide to tirzepatide?

Tirzepatide produced greater average weight loss than semaglutide in a 72-week head-to-head trial involving adults with obesity without diabetes.[4] Nevertheless, switching depends on medical history, indications, side effects, coverage and access. The medications should not be combined.

Bottom line

Semaglutide not producing immediate or continuous weight loss does not automatically mean the medication has failed.

The most common explanations include:

• Being early in treatment
• Remaining on an introductory dose
• Normal weight fluctuations
• A genuine weight-loss plateau
• Calorie-dense foods or beverages
• Decreased daily activity
• Missed doses or administration problems
• Poor sleep, stress or alcohol
• Weight-promoting medications
• Another medical condition
• A lower-than-average individual response

Track the pattern, verify how the medication is being used and review the complete situation with your prescriber. Do not try to overcome a plateau by changing the dose or combining medications independently.

---

Medical review: Mark Aquino, MSN, APRN, FNP-C, board-certified family nurse practitioner.

Medical disclaimer: This article provides general educational information and is not a diagnosis or individualized treatment plan. Semaglutide requires evaluation, prescribing and monitoring by a qualified healthcare professional. Never start, stop, combine or change the dose of prescription medication based solely on online information.

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183.
2. Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091. doi:10.1038/s41591-022-02026-4.
3. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. doi:10.1111/dom.14725.
4. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393(1):26-36. doi:10.1056/NEJMoa2416394.